Katie Thomas is an accomplished marketing research and competitive intelligence professional with extensive experience in the pharmaceuticals industry. Currently serving as Director of Market Research & CI at Alkermes since June 2016, Katie leads a team focused on critical treatment options for patients with schizophrenia and bipolar I disorder, providing actionable insights to cross-functional groups. Prior to this role, Katie held various positions at Boehringer Ingelheim, specializing in cardiovascular market research, and has also contributed strategic insights at Element Marketing Group, Affinion Group, and Boehringer Ingelheim Pharmaceuticals. Katie holds an MBA in Entrepreneurship from Pace University and a BBA in Business Management from James Madison University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices